International Alert on Mpox

In July, the World Health Organization declared an international health emergency over the spread of mpox, a disease first identified in humans in 1970 in the Democratic Republic of Congo (DRC). Originally called monkeypox, the disease primarily affected certain African countries, with mortality rates historically ranging from 1% to 10%.

Varied Impact Across Regions

The mpox virus emerged in Western countries in 2022, with a notably low mortality rate of around 0.2%. This lower death rate contrasts with African nations and is attributed to faster, more effective medical responses in the U.S. and Europe. These disparities highlight the impact of varying healthcare quality on disease outcomes. According to virologist Antoine Gessain, the level of basic healthcare significantly influences the risk posed by the disease.

The Burden of Malnutrition

In the DRC, the majority of mpox-related deaths have been among children, severely impacted by malnutrition.The DRC’s 2022-23 outbreak saw primarily HIV-compromised adults succumb, starkly contrasting with other regions. This highlights the profound impact that underlying health conditions have on the outcomes of diseases. Such differences emphasize the critical role health statuses play in determining the severity of disease impacts.

Transmission and Viral Families

The recent mpox spread mainly through sexual contact among homosexual and bisexual men signifies a change in transmission dynamics. The virus is categorized into several clades; Clade 1 is linked to more severe cases compared to Clade 2. Clade 2, found mostly in Western Africa, presents milder symptoms and outcomes.

Complexity in Clade Comparisons

The current epidemic in the DRC stems from Clade 1, with a concerning variant known as 1b driving a separate epidemic among adults. This variant’s emergence has caused confusion and concern about its potential severity and transmission rates. Dutch virologist Marion Koopmans stated that media claims about sublineage 1b’s transmissibility and severity lack sufficient evidence.

Ongoing Research and Vigilance Needed

The recent detection of Clade 1 in Sweden in mid-July underscores the urgent need for ongoing research and clear facts. The impacts of different mpox clades vary, influenced by demographic and health contexts, complicating direct comparisons. Understanding mpox requires a nuanced approach, considering the complex interplay of factors affecting disease severity.

Further reading

Follow us on Socials:
Twitter
Facebook